Protein CHRM1 Combats Drug Resistance in Prostate Cancer Treatment : vimarsana.com

In prostate cancer, the minimum effective dose of docetaxel may be reduced when combined with dicyclomine, in contrast to its solo administration.

Related Keywords

, Boyang Jason Wu , College Of Pharmacy , Pharmaceutical Sciences , Dicyclomine Combination Shows Promise , Overcoming Prostate Cancer Treatment Resistance , Cell Reports Medicine , Prostate Cancer , Rostate Gland , Rug Resistance ,